Tivic Health Systems (TIVC) Competitors $3.18 -0.02 (-0.63%) As of 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TIVC vs. NXL, MHUA, TNON, XAIR, LYRA, OSRH, INBS, CODX, POAI, and SINTShould you be buying Tivic Health Systems stock or one of its competitors? The main competitors of Tivic Health Systems include Nexalin Technology (NXL), Meihua International Medical Technologies (MHUA), Tenon Medical (TNON), Beyond Air (XAIR), Lyra Therapeutics (LYRA), OSR (OSRH), Intelligent Bio Solutions (INBS), Co-Diagnostics (CODX), Predictive Oncology (POAI), and Sintx Technologies (SINT). These companies are all part of the "medical equipment" industry. Tivic Health Systems vs. Its Competitors Nexalin Technology Meihua International Medical Technologies Tenon Medical Beyond Air Lyra Therapeutics OSR Intelligent Bio Solutions Co-Diagnostics Predictive Oncology Sintx Technologies Tivic Health Systems (NASDAQ:TIVC) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership. Do institutionals and insiders hold more shares of TIVC or NXL? 4.3% of Tivic Health Systems shares are owned by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are owned by institutional investors. 0.5% of Tivic Health Systems shares are owned by company insiders. Comparatively, 25.3% of Nexalin Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is TIVC or NXL more profitable? Tivic Health Systems has a net margin of -148.49% compared to Nexalin Technology's net margin of -5,057.14%. Tivic Health Systems' return on equity of -22.69% beat Nexalin Technology's return on equity.Company Net Margins Return on Equity Return on Assets Tivic Health Systems-148.49% -22.69% -18.94% Nexalin Technology -5,057.14%-209.20%-186.87% Does the media refer more to TIVC or NXL? In the previous week, Nexalin Technology had 2 more articles in the media than Tivic Health Systems. MarketBeat recorded 3 mentions for Nexalin Technology and 1 mentions for Tivic Health Systems. Tivic Health Systems' average media sentiment score of 0.00 equaled Nexalin Technology'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tivic Health Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nexalin Technology 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better valuation and earnings, TIVC or NXL? Tivic Health Systems has higher revenue and earnings than Nexalin Technology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTivic Health Systems$780K4.40N/AN/AN/ANexalin Technology$170K86.90-$7.61M-$0.76-1.12 Do analysts recommend TIVC or NXL? Nexalin Technology has a consensus price target of $5.00, suggesting a potential upside of 489.62%. Given Nexalin Technology's stronger consensus rating and higher possible upside, analysts plainly believe Nexalin Technology is more favorable than Tivic Health Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tivic Health Systems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, TIVC or NXL? Tivic Health Systems has a beta of 1.98, suggesting that its stock price is 98% more volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 3.69, suggesting that its stock price is 269% more volatile than the S&P 500. SummaryNexalin Technology beats Tivic Health Systems on 7 of the 12 factors compared between the two stocks. Get Tivic Health Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for TIVC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TIVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TIVC vs. The Competition Export to ExcelMetricTivic Health SystemsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.43M$2.11B$5.76B$9.75BDividend YieldN/AN/A4.40%4.10%P/E RatioN/A37.7230.8325.91Price / Sales4.4013.51469.77121.46Price / CashN/A53.5525.7828.79Price / Book0.7010.789.466.03Net IncomeN/A-$63.67M$3.27B$265.29M7 Day Performance-3.93%1.20%2.37%2.86%1 Month Performance-23.92%0.68%3.88%1.23%1 Year Performance-45.32%24.06%30.52%19.11% Tivic Health Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TIVCTivic Health Systems0.216 of 5 stars$3.18-0.6%N/A-45.0%$3.43M$780K0.0010Gap DownNXLNexalin Technology2.4274 of 5 stars$0.74-8.0%$5.00+575.7%+5.9%$12.89M$170K-0.973News CoverageGap DownMHUAMeihua International Medical Technologies0.3674 of 5 stars$0.40-0.7%N/A-43.8%$12.79M$96.90M0.00620TNONTenon Medical1.5349 of 5 stars$1.41-0.7%$5.50+290.1%+175.9%$12.52M$3.28M-0.058Gap DownXAIRBeyond Air4.1433 of 5 stars$2.29-4.6%$11.00+380.6%-75.8%$11.89M$4.78M-0.1970LYRALyra Therapeutics3.3363 of 5 stars$7.04-3.7%$100.00+1,320.5%-53.6%$11.57M$1.53M-0.2450Gap DownOSRHOSRN/A$0.53-5.7%N/AN/A$10.22MN/A0.00N/APositive NewsGap UpINBSIntelligent Bio Solutions0.4855 of 5 stars$1.47-2.3%N/A+25.4%$10.16M$3.05M-0.7210CODXCo-Diagnostics4.33 of 5 stars$0.29-9.1%$5.50+1,790.0%-81.8%$9.74M$3.91M-0.25100Gap DownPOAIPredictive Oncology0.5095 of 5 stars$0.88+3.1%N/A+0.0%$9.59M$1.66M-0.2930Gap UpSINTSintx Technologies2.1072 of 5 stars$3.27+2.7%$28.00+757.6%-19.0%$8.94M$2.89M-0.0640News Coverage Related Companies and Tools Related Companies Nexalin Technology Alternatives Meihua International Medical Technologies Alternatives Tenon Medical Alternatives Beyond Air Alternatives Lyra Therapeutics Alternatives OSR Alternatives Intelligent Bio Solutions Alternatives Co-Diagnostics Alternatives Predictive Oncology Alternatives Sintx Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TIVC) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tivic Health Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tivic Health Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access